
Sign up to save your podcasts
Or


Dr Kimberly H Allison from Stanford Cancer Institute in Stanford, California, discusses the optimal identification, pathologic reporting and treatment of HER2-low breast cancer.
By Dr. Neil Love4.4
6262 ratings
Dr Kimberly H Allison from Stanford Cancer Institute in Stanford, California, discusses the optimal identification, pathologic reporting and treatment of HER2-low breast cancer.

138 Listeners

323 Listeners

498 Listeners

30 Listeners

76 Listeners

14 Listeners

17 Listeners

12 Listeners

0 Listeners

121 Listeners

57 Listeners

294 Listeners

3,361 Listeners

205 Listeners

515 Listeners

59 Listeners

193 Listeners

0 Listeners